{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T03:10:09Z","timestamp":1751771409399,"version":"3.41.0"},"publisher-location":"Cham","reference-count":145,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319908076"},{"type":"electronic","value":"9783319908083"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-3-319-90808-3_11","type":"book-chapter","created":{"date-parts":[[2018,7,28]],"date-time":"2018-07-28T16:24:17Z","timestamp":1532795057000},"page":"259-280","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Adenosine Receptors in Alzheimer\u2019s Disease"],"prefix":"10.1007","author":[{"given":"Paula M.","family":"Canas","sequence":"first","affiliation":[]},{"given":"Rodrigo A.","family":"Cunha","sequence":"additional","affiliation":[]},{"given":"Paula","family":"Agostinho","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,7,29]]},"reference":[{"key":"11_CR1","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.2174\/138161210793176572","volume":"16","author":"P Agostinho","year":"2010","unstructured":"Agostinho P, Cunha RA, Oliveira C (2010) Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer\u2019s disease. Curr Pharm Des 16:2766\u20132778","journal-title":"Curr Pharm Des"},{"key":"11_CR2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3233\/JAD-142730","volume":"45","author":"P Agostinho","year":"2015","unstructured":"Agostinho P, Pli\u00e1ssova A, Oliveira CR et al (2015) Localization and trafficking of amyloid-\u03b2 protein precursor and secretases: impact on Alzheimer\u2019s disease. J Alzheimers Dis 45:329\u2013347","journal-title":"J Alzheimers Dis"},{"key":"11_CR3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","volume":"21","author":"H Akiyama","year":"2000","unstructured":"Akiyama H, Barger S, Barnum S et al (2000) Inflammation and Alzheimer\u2019s disease. Neurobiol Aging 21:383\u2013421","journal-title":"Neurobiol Aging"},{"key":"11_CR4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1750-3639.2007.00112.x","volume":"18","author":"JL Albasanz","year":"2008","unstructured":"Albasanz JL, Perez S, Barrachina M et al (2008) Up-regulation of adenosine receptors in the frontal cortex in Alzheimer\u2019s disease. Brain Pathol 18:211\u2013219","journal-title":"Brain Pathol"},{"key":"11_CR5","doi-asserted-by":"crossref","first-page":"C696","DOI":"10.1152\/ajpcell.00202.2002","volume":"284","author":"I Allaman","year":"2003","unstructured":"Allaman I, Lengacher S, Magistretti PJ et al (2003) A2B receptor activation promotes glycogen synthesis in astrocytes through modulation of gene expression. Am J Phys 284:C696\u2013C704","journal-title":"Am J Phys"},{"key":"11_CR6","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1750-3639.2003.tb00475.x","volume":"13","author":"E Angulo","year":"2003","unstructured":"Angulo E, Casado V, Mallol J et\u00a0al (2003) A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation. Brain Pathol 13:440\u2013451","journal-title":"Brain Pathol"},{"key":"11_CR7","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.neuroscience.2006.07.021","volume":"142","author":"GW Arendash","year":"2006","unstructured":"Arendash GW, Schleif W, Rezai-Zadeh K et al (2006) Caffeine protects Alzheimer\u2019s mice against cognitive impairment and reduces brain beta-amyloid production. Neuroscience 142:941\u2013952","journal-title":"Neuroscience"},{"key":"11_CR8","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3233\/JAD-2009-1087","volume":"17","author":"GW Arendash","year":"2009","unstructured":"Arendash GW, Mori T, Cao C et al (2009) Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer\u2019s disease mice. J Alzheimers Dis 17:661\u2013680","journal-title":"J Alzheimers Dis"},{"key":"11_CR9","doi-asserted-by":"crossref","first-page":"31493","DOI":"10.1038\/srep31493","volume":"6","author":"VL Batalha","year":"2016","unstructured":"Batalha VL, Ferreira DG, Coelho JE et al (2016) The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function. Sci Rep 6:31493","journal-title":"Sci Rep"},{"key":"11_CR10","doi-asserted-by":"crossref","first-page":"R135","DOI":"10.1093\/hmg\/ddh077","volume":"13","author":"L Bertram","year":"2004","unstructured":"Bertram L, Tanzi RE (2004) Alzheimer\u2019s disease: one disorder, too many genes? Hum Mol Genet 13:R135\u2013R141","journal-title":"Hum Mol Genet"},{"key":"11_CR11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","volume":"368","author":"K Blennow","year":"2006","unstructured":"Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer\u2019s disease. Lancet 368:387\u2013403","journal-title":"Lancet"},{"key":"11_CR12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","volume":"6","author":"K Blennow","year":"2010","unstructured":"Blennow K, Hampel H, Weiner M et al (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6:131\u2013144","journal-title":"Nat Rev Neurol"},{"key":"11_CR13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"11_CR14","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/0896-6273(93)90057-X","volume":"10","author":"GT Bramblett","year":"1993","unstructured":"Bramblett GT, Goedert M, Jakes R et al (1993) Abnormal tau phosphorylation at Ser396 in Alzheimer\u2019s disease recapitulates development and contributes to reduced microtubule binding. Neuron 10:1089\u20131099","journal-title":"Neuron"},{"doi-asserted-by":"crossref","unstructured":"Burckhardt M, Herke M, Wustmann T et al (2016) Omega-3 fatty acids for the treatment of dementia. Cochrane Database Syst Rev 4:CD009002","key":"11_CR15","DOI":"10.1002\/14651858.CD009002.pub3"},{"key":"11_CR16","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2174\/156802611795347627","volume":"11","author":"G Burnstock","year":"2011","unstructured":"Burnstock G, Fredholm BB, Verkhratsky A (2011) Adenosine and ATP receptors in the brain. Curr Top Med Chem 11:973\u20131011","journal-title":"Curr Top Med Chem"},{"key":"11_CR17","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.neurobiolaging.2008.01.003","volume":"30","author":"PM Canas","year":"2009","unstructured":"Canas PM, Duarte JM, Rodrigues RJ et al (2009a) Modification upon aging of the density of presynaptic modulation systems in the hippocampus. Neurobiol Aging 30:1877\u20131884","journal-title":"Neurobiol Aging"},{"key":"11_CR18","doi-asserted-by":"crossref","first-page":"14741","DOI":"10.1523\/JNEUROSCI.3728-09.2009","volume":"29","author":"PM Canas","year":"2009","unstructured":"Canas PM, Porci\u00fancula LO, Cunha GM et al (2009b) Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway. J Neurosci 29:14741\u201314751","journal-title":"J Neurosci"},{"key":"11_CR19","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3233\/JAD-2009-1071","volume":"17","author":"C Cao","year":"2009","unstructured":"Cao C, Cirrito JR, Lin X et al (2009) Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer\u2019s disease transgenic mice. J Alzheimers Dis 17:681\u2013697","journal-title":"J Alzheimers Dis"},{"key":"11_CR20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3233\/JAD-2012-111781","volume":"30","author":"C Cao","year":"2012","unstructured":"Cao C, Loewenstein DA, Lin X et al (2012) High blood caffeine levels in MCI linked to lack of progression to dementia. J Alzheimers Dis 30:559\u2013572","journal-title":"J Alzheimers Dis"},{"key":"11_CR21","doi-asserted-by":"crossref","first-page":"13272","DOI":"10.1523\/JNEUROSCI.3337-11.2011","volume":"31","author":"AJ Carman","year":"2011","unstructured":"Carman AJ, Mills JH, Krenz A et al (2011) Adenosine receptor signaling modulates permeability of the blood-brain barrier. J Neurosci 31:13272\u201313280","journal-title":"J Neurosci"},{"key":"11_CR22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.exger.2009.04.006","volume":"44","author":"CA Castillo","year":"2009","unstructured":"Castillo CA, Albasanz JL, Leon D et al (2009) Age-related expression of adenosine receptors in brain from the senescence-accelerated mouse. Exp Gerontol 44:453\u2013461","journal-title":"Exp Gerontol"},{"key":"11_CR23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/B978-0-12-801022-8.00012-X","volume":"119","author":"JF Chen","year":"2014","unstructured":"Chen JF (2014) Adenosine receptor control of cognition in normal and disease. Int Rev Neurobiol 119:257\u2013307","journal-title":"Int Rev Neurobiol"},{"key":"11_CR24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pneurobio.2013.06.004","volume":"108","author":"Z Chen","year":"2013","unstructured":"Chen Z, Zhong C (2013) Decoding Alzheimer\u2019s disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Prog Neurobiol 108:21\u201343","journal-title":"Prog Neurobiol"},{"key":"11_CR25","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1002\/jnr.21071","volume":"84","author":"GJ Chen","year":"2006","unstructured":"Chen GJ, Harvey BK, Shen H et al (2006) Activation of adenosine A3 receptors reduces ischemic brain injury in rodents. J Neurosci Res 84:1848\u20131855","journal-title":"J Neurosci Res"},{"key":"11_CR26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0304-3940(00)00961-7","volume":"283","author":"J Cheng","year":"2000","unstructured":"Cheng J, Liu I, Juang S et al (2000) Decrease of adenosine A-1 receptor gene expression in cerebral cortex of aged rats. Neurosci Lett 283:227\u2013229","journal-title":"Neurosci Lett"},{"key":"11_CR27","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1523\/JNEUROSCI.3574-05.2006","volume":"26","author":"F Ciruela","year":"2006","unstructured":"Ciruela F, Casad\u00f3 V, Rodrigues RJ et al (2006) Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J Neurosci 26:2080\u20132087","journal-title":"J Neurosci"},{"key":"11_CR28","doi-asserted-by":"crossref","first-page":"13170","DOI":"10.1073\/pnas.93.23.13170","volume":"93","author":"M Citron","year":"1996","unstructured":"Citron M, Diehl TS, Gordon G et al (1996) Evidence that the 42- and 40-amino acid forms of amyloid \u03b2 protein are generated from the \u03b2-amyloid precursor protein by different proteas activities. PNAS 93:13170\u201313175","journal-title":"PNAS"},{"key":"11_CR29","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1471-4159.2009.06465.x","volume":"112","author":"GP Cognato","year":"2010","unstructured":"Cognato GP, Agostinho PM Hockemeyer J et\u00a0al (2010) Caffeine and an adenosine A2A receptor antagonist prevent memory impairment and synaptotoxicity in adult rats triggered by a convulsive episode in early life. J Neurochem 112:453\u2013462","journal-title":"J Neurochem"},{"key":"11_CR30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1460-9568.2011.07719.x","volume":"34","author":"AR Costenla","year":"2011","unstructured":"Costenla AR, Di\u00f3genes MJ, Canas PM et al (2011) Enhanced role of adenosine A2A receptors in the modulation of LTP in the rat hippocampus upon ageing. Eur J Neurosci 34:12\u201321","journal-title":"Eur J Neurosci"},{"key":"11_CR31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13195-017-0297-z","volume":"9","author":"M Crous-Bou","year":"2017","unstructured":"Crous-Bou M, Minguill\u00f3n C, Gramunt N et al (2017) Alzheimer\u2019s disease prevention: from risk factors to early intervention. Alzheimers Res Ther 9:71","journal-title":"Alzheimers Res Ther"},{"key":"11_CR32","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/jnc.13724","volume":"139","author":"RA Cunha","year":"2016","unstructured":"Cunha RA (2016) How does adenosine control neuronal dysfunction and neurodegeneration? J Neurochem 139:1019\u20131055","journal-title":"J Neurochem"},{"unstructured":"Cunha RA, Agostinho PM (2010) Chronic caffeine consumption prevents memory disturbance in different animal models of memory decline. J Alzheimers Dis 20(Suppl 1):S95\u2013116","key":"11_CR33"},{"key":"11_CR34","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/00001756-199507310-00029","volume":"6","author":"RA Cunha","year":"1995","unstructured":"Cunha RA, Constantino MC, Sebasti\u00e3o AM et al (1995) Modification of A1 and A2A adenosine receptor binding in aged striatum, hippocampus and cortex of the rat. Neuroreport 6:1583\u20131588","journal-title":"Neuroreport"},{"key":"11_CR35","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.expneurol.2007.11.013","volume":"210","author":"GM Cunha","year":"2008","unstructured":"Cunha GM, Canas PM, Melo C et al (2008) Adenosine A2A receptor blockade prevents memory dysfunction caused by beta-amyloid peptides but not by scopolamine or MK-801. Exp Neurol 210:776\u2013781","journal-title":"Exp Neurol"},{"key":"11_CR36","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.bjp.0705185","volume":"138","author":"OP Dall\u2019Igna","year":"2003","unstructured":"Dall\u2019Igna OP, Porci\u00fancula LO, Souza DO et al (2003) Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity. Br J Pharmacol 138:1207\u20131209","journal-title":"Br J Pharmacol"},{"key":"11_CR37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.expneurol.2006.08.008","volume":"203","author":"OP Dall\u2019Igna","year":"2007","unstructured":"Dall\u2019Igna OP, Fett P, Gomes MW et al (2007) Caffeine and adenosine A2A receptor antagonists prevent beta-amyloid25-35-induced cognitive deficits in mice. Exp Neurol 203:241\u2013245","journal-title":"Exp Neurol"},{"key":"11_CR38","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0165-0173(00)00033-3","volume":"33","author":"A Mendon\u00e7a de","year":"2000","unstructured":"de Mendon\u00e7a A, Sebasti\u00e3o AM, Ribeiro JA (2000) Adenosine: does it have a neuroprotective role after all? Brain Res Rev 33:258\u2013274","journal-title":"Brain Res Rev"},{"doi-asserted-by":"crossref","unstructured":"De Strooper B, Karran E (2016) The cellular phase of Alzheimer\u2019s disease. Cell 164:603\u2013615","key":"11_CR39","DOI":"10.1016\/j.cell.2015.12.056"},{"key":"11_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3940(98)00108-6","volume":"244","author":"J Deckert","year":"1998","unstructured":"Deckert J, Abel F, K\u00fcnig G et al (1998) Loss of human hippocampal adenosine A1 receptors in dementia: evidence for lack of specificity. Neurosci Lett 244:1\u20134","journal-title":"Neurosci Lett"},{"key":"11_CR41","doi-asserted-by":"crossref","first-page":"11597","DOI":"10.1073\/pnas.1603119113","volume":"113","author":"FJ Dennissen","year":"2016","unstructured":"Dennissen FJ, Anglada-Huguet M, Sydow A et al (2016) Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human tau DeltaK280. PNAS 113:11597\u201311602","journal-title":"PNAS"},{"key":"11_CR42","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1155\/2009\/610392","volume":"21","author":"BC Dickerson","year":"2009","unstructured":"Dickerson BC, Sperling RA (2009) Large-scale functional brain network abnormalities in Alzheimer\u2019s disease: insights from functional neuroimaging. Behav Neurol 21:63\u201375","journal-title":"Behav Neurol"},{"key":"11_CR43","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.neuropharm.2012.08.018","volume":"63","author":"N Dragicevic","year":"2012","unstructured":"Dragicevic N, Delic V, Cao C et al (2012) Caffeine increases mitochondrial function and blocks melatonin signaling to mitochondria in Alzheimer\u2019s mice and cells. Neuropharmacology 63:1368\u20131379","journal-title":"Neuropharmacology"},{"key":"11_CR44","doi-asserted-by":"crossref","first-page":"e21899","DOI":"10.1371\/journal.pone.0021899","volume":"7","author":"JM Duarte","year":"2012","unstructured":"Duarte JM, Agostinho PM, Carvalho RA et al (2012) Caffeine consumption prevents diabetes-induced memory impairment and synaptotoxicity in the hippocampus of NONcZNO10\/LTJ mice. PLoS One 7:e21899","journal-title":"PLoS One"},{"key":"11_CR45","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","volume":"9","author":"B Dubois","year":"2010","unstructured":"Dubois B, Feldman HH, Jacova C et al (2010) Revising the definition of Alzheimer\u2019s disease: a new lexicon. Lancet Neurol 9:1118\u20131127","journal-title":"Lancet Neurol"},{"key":"11_CR46","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/nn.3806","volume":"17","author":"JA Elman","year":"2014","unstructured":"Elman JA, Oh H, Madison CM et al (2014) Neural compensation in older people with brain \u03b2-amyloid deposition. Nat Neurosci 17:1316\u20131318","journal-title":"Nat Neurosci"},{"key":"11_CR47","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3233\/JAD-111982","volume":"34","author":"J Espinosa","year":"2013","unstructured":"Espinosa J, Rocha A, Nunes F et al (2013) Caffeine consumption prevents memory impairment, neuronal damage, and adenosine A2A receptors upregulation in the hippocampus of a rat model of sporadic dementia. J Alzheimers Dis 34:509\u2013518","journal-title":"J Alzheimers Dis"},{"key":"11_CR48","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1042\/BST20130229","volume":"42","author":"V Flaten","year":"2014","unstructured":"Flaten V, Laurent C, Coelho JE et al (2014) From epidemiology to pathophysiology: what about caffeine in Alzheimer\u2019s disease? Biochem Soc Trans 42:587\u2013592","journal-title":"Biochem Soc Trans"},{"key":"11_CR49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0031-6997(24)01396-6","volume":"51","author":"BB Fredholm","year":"1999","unstructured":"Fredholm BB, B\u00e4ttig K, Holm\u00e9n J et\u00a0al (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51:83\u2013133","journal-title":"Pharmacol Rev"},{"key":"11_CR50","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0074-7742(05)63007-3","volume":"63","author":"BB Fredholm","year":"2005","unstructured":"Fredholm BB, Chen JF, Cunha RA et al (2005) Adenosine and brain function. Int Rev Neurobiol 63:191\u2013270","journal-title":"Int Rev Neurobiol"},{"key":"11_CR51","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1056\/NEJMoa1112010","volume":"366","author":"ND Freedman","year":"2012","unstructured":"Freedman ND, Park Y, Abnet CC et al (2012) Association of coffee drinking with total and cause-specific mortality. N Engl J Med 366:1891\u20131904","journal-title":"N Engl J Med"},{"doi-asserted-by":"crossref","unstructured":"Fukumitsu N, Ishii K, Kimura Y et al (2008) Adenosine A1 receptors using 8-dicyclopropylmethyl-1-[(11)C]methyl-3-propylxanthine PET in Alzheimer's disease. Ann Nucl Med 22:841\u2013847","key":"11_CR146","DOI":"10.1007\/s12149-008-0185-5"},{"key":"11_CR52","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.exer.2015.08.009","volume":"140","author":"J Galv\u00e3o","year":"2015","unstructured":"Galv\u00e3o J, Elvas F, Martins T et al (2015) Adenosine A3 receptor activation is neuroprotective against retinal neurodegeneration. Exp Eye Res 140:65\u201374","journal-title":"Exp Eye Res"},{"key":"11_CR53","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.bbamem.2010.12.001","volume":"1808","author":"CV Gomes","year":"2011","unstructured":"Gomes CV, Kaster MP, Tom\u00e9 AR et al (2011) Adenosine receptors and brain diseases: neuroprotection and neurodegeneration. Biochim Biophys Acta 1808:1380\u20131399","journal-title":"Biochim Biophys Acta"},{"key":"11_CR54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410410106","volume":"41","author":"T G\u00f3mez-Isla","year":"1997","unstructured":"G\u00f3mez-Isla T, Hollister R, West H et al (1997) Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer\u2019s disease. Ann Neurol 41:17\u201324","journal-title":"Ann Neurol"},{"key":"11_CR55","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-131652","volume":"40","author":"C Gussago","year":"2014","unstructured":"Gussago C, Arosio B, Casati M et al (2014) Different adenosine A2A receptor expression in peripheral cells from elderly patients with vascular dementia and Alzheimer\u2019s disease. J Alzheimers Dis 40:45\u201349","journal-title":"J Alzheimers Dis"},{"key":"11_CR56","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.neuroscience.2016.05.061","volume":"330","author":"S Gyoneva","year":"2016","unstructured":"Gyoneva S, Swanger SA, Zhang J et\u00a0al (2016) Altered motility of plaque-associated microglia in a model of Alzheimer\u2019s disease. Neuroscience 330:410\u2013420","journal-title":"Neuroscience"},{"key":"11_CR57","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA (1992) Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science 256:184\u2013185","journal-title":"Science"},{"key":"11_CR58","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297:353\u2013356","journal-title":"Science"},{"key":"11_CR59","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3233\/JAD-2011-111217","volume":"28","author":"CR Hooijmans","year":"2012","unstructured":"Hooijmans CR, Pasker-de Jong PC, de Vries RB et al (2012) The effects of long-term omega-3 fatty acid supplementation on cognition and Alzheimer\u2019s pathology in animal models of Alzheimer\u2019s disease: a systematic review and meta-analysis. J Alzheimers Dis 28:191\u2013209","journal-title":"J Alzheimers Dis"},{"key":"11_CR60","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","volume":"148","author":"Y Huang","year":"2012","unstructured":"Huang Y, Mucke L (2012) Alzheimer mechanisms and therapeutic strategies. Cell 148:1204\u20131222","journal-title":"Cell"},{"key":"11_CR61","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.6474172","volume":"225","author":"BT Hyman","year":"1984","unstructured":"Hyman BT, Van Hoesen GW, Damasio AR et al (1984) Alzheimer\u2019s disease: cell-specific pathology isolates the hippocampal formation. Science 225:1168\u20131170","journal-title":"Science"},{"key":"11_CR62","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/brain\/aws013","volume":"135","author":"DJ Irwin","year":"2012","unstructured":"Irwin DJ, Cohen TJ, Grossman M et al (2012) Acetylated tau, a novel pathological signature in Alzheimer\u2019s disease and other tauopathies. Brain 135:807\u2013818","journal-title":"Brain"},{"key":"11_CR63","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0165-6147(96)10002-X","volume":"17","author":"KA Jacobson","year":"1996","unstructured":"Jacobson KA, von Lubitz DKJE, Daly JW et al (1996) Adenosine receptor ligands: differences with acute versus chronic treatment. Trends Pharmacol Sci 17:108\u2013113","journal-title":"Trends Pharmacol Sci"},{"key":"11_CR64","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0304-3940(90)90641-L","volume":"118","author":"RN Kalaria","year":"1990","unstructured":"Kalaria RN, Sromek S, Wilcox BJ et al (1990) Hippocampal adenosine A1 receptors are decreased in Alzheimer\u2019s disease. Neurosci Lett 118:257\u2013260","journal-title":"Neurosci Lett"},{"key":"11_CR65","doi-asserted-by":"crossref","first-page":"7833","DOI":"10.1073\/pnas.1423088112","volume":"112","author":"MP Kaster","year":"2015","unstructured":"Kaster MP, Machado NJ, Silva HB et al (2015) Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress. PNAS 112:7833\u20137838","journal-title":"PNAS"},{"key":"11_CR66","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3389\/fphar.2017.00899","volume":"8","author":"A Kerkhofs","year":"2018","unstructured":"Kerkhofs A, Xavier AC, Silva BS et al (2018) Caffeine controls glutamatergic synaptic transmission and pyramidal neuron excitability in human neocortex. Front Pharmacol 8:899","journal-title":"Front Pharmacol"},{"key":"11_CR67","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1073\/pnas.0811698106","volume":"106","author":"RM Koffie","year":"2009","unstructured":"Koffie RM, Meyer-Luehmann M, Hashimoto T et al (2009) Oligomeric amyloid \u03b2 associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. PNAS 106:4012\u20134017","journal-title":"PNAS"},{"key":"11_CR68","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.neurobiolaging.2014.03.027","volume":"35","author":"C Laurent","year":"2014","unstructured":"Laurent C, Eddarkaoui S, Derisbourg M et al (2014) Beneficial effects of caffeine in a transgenic model of Alzheimer\u2019s disease-like tau pathology. Neurobiol Aging 35:2079\u20132090","journal-title":"Neurobiol Aging"},{"key":"11_CR69","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/mp.2014.151","volume":"21","author":"C Laurent","year":"2016","unstructured":"Laurent C, Burnouf S, Ferry B et al (2016) A2A adenosine receptor deletion is protective in a mouse model of Tauopathy. Mol Psychiatry 21:97\u2013107","journal-title":"Mol Psychiatry"},{"key":"11_CR70","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.exger.2010.11.034","volume":"46","author":"MR Leite","year":"2011","unstructured":"Leite MR, Wilhelm EA, Jesse CR et al (2011) Protective effect of caffeine and a selective A2A receptor antagonist on impairment of memory and oxidative stress of aged rats. Exp Gerontol 46:309\u2013315","journal-title":"Exp Gerontol"},{"key":"11_CR71","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s11302-015-9474-3","volume":"11","author":"C Lemos","year":"2015","unstructured":"Lemos C, Pinheiro BS, Beleza RO et al (2015) Adenosine A2B receptor activation stimulates glucose uptake in the mouse forebrain. Purinergic Signal 11:561\u2013569","journal-title":"Purinergic Signal"},{"key":"11_CR72","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/brain\/awt062","volume":"136","author":"SE Lesn\u00e9","year":"2013","unstructured":"Lesn\u00e9 SE, Sherman MA, Grant M et al (2013) Brain amyloid-\u03b2 oligomers in ageing and Alzheimer\u2019s disease. Brain 136:1383\u20131398","journal-title":"Brain"},{"key":"11_CR73","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/mp.2015.43","volume":"20","author":"P Li","year":"2015","unstructured":"Li P, Rial D, Canas PM et al (2015a) Optogenetic activation of intracellular adenosine A2A receptor signaling in the hippocampus is sufficient to trigger CREB phosphorylation and impair memory. Mol Psychiatry 20:1481","journal-title":"Mol Psychiatry"},{"key":"11_CR74","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3233\/JAD-142223","volume":"47","author":"S Li","year":"2015","unstructured":"Li S, Geiger NH, Soliman ML et al (2015b) Caffeine, through adenosine A3 receptor-mediated actions, suppresses amyloid-beta protein precursor internalization and amyloid-beta generation. J Alzheimers Dis 47:73\u201383","journal-title":"J Alzheimers Dis"},{"key":"11_CR75","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu CC, Liu CC, Kanekiyo T et al (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9:106\u2013118","journal-title":"Nat Rev Neurol"},{"key":"11_CR76","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1152\/jn.1999.82.6.3196","volume":"82","author":"LV Lopes","year":"1999","unstructured":"Lopes LV, Cunha RA, Ribeiro JA (1999a) Cross talk between A1 and A2A adenosine receptors in the hippocampus and cortex of young adult and old rats. J Neurophysiol 82:3196\u20133203","journal-title":"J Neurophysiol"},{"key":"11_CR77","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1046\/j.1471-4159.1999.731733.x","volume":"73","author":"LV Lopes","year":"1999","unstructured":"Lopes LV, Cunha RA, Ribeiro JA (1999b) Increase in the number, G protein coupling, and efficiency of facilitatory adenosine A2A receptors in the limbic cortex, but not striatum, of aged rats. J Neurochem 73:1733\u20131738","journal-title":"J Neurochem"},{"key":"11_CR78","doi-asserted-by":"crossref","first-page":"e0166415","DOI":"10.1371\/journal.pone.0166415","volume":"11","author":"J Lu","year":"2016","unstructured":"Lu J, Cui J, Li X et al (2016) An anti-Parkinson\u2019s disease drug via targeting adenosine A2A receptor enhances amyloid-beta generation and gamma-secretase activity. PLoS One 11:e0166415","journal-title":"PLoS One"},{"key":"11_CR79","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1515\/REVNEURO.1999.10.2.117","volume":"10","author":"SJ Lupien","year":"1999","unstructured":"Lupien SJ, Nair NP, Bri\u00e8re S et al (1999) Increased cortisol levels and impaired cognition in human aging: implication for depression and dementia in later life. Rev Neurosci 10:117\u2013139","journal-title":"Rev Neurosci"},{"key":"11_CR80","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s12035-016-9774-9","volume":"54","author":"NJ Machado","year":"2017","unstructured":"Machado NJ, Sim\u00f5es AP, Silva HB et al (2017) Caffeine reverts memory but not mood impairment in a depression-prone mouse strain with up-regulated adenosine A2A receptor in hippocampal glutamate synapses. Mol Neurobiol 54:1552\u20131563","journal-title":"Mol Neurobiol"},{"key":"11_CR81","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1523\/JNEUROSCI.06-09-02558.1986","volume":"6","author":"PJ Magistretti","year":"1986","unstructured":"Magistretti PJ, Hof PR, Martin JL (1986) Adenosine stimulates glycogenolysis in mouse cerebral cortex: a possible coupling mechanism between neuronal activity and energy metabolism. J Neurosci 6:2558\u20132562","journal-title":"J Neurosci"},{"key":"11_CR82","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1468-1331.2002.00421.x","volume":"9","author":"L Maia","year":"2002","unstructured":"Maia L, de Mendon\u00e7a A (2002) Does caffeine intake protect from Alzheimer\u2019s disease? Eur J Neurol 9:377\u2013382","journal-title":"Eur J Neurol"},{"key":"11_CR83","doi-asserted-by":"crossref","first-page":"e6617","DOI":"10.1371\/journal.pone.0006617","volume":"4","author":"D Mastroeni","year":"2009","unstructured":"Mastroeni D, McKee A, Grover A et al (2009) Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer\u2019s disease. PLoS One 4:e6617","journal-title":"PLoS One"},{"key":"11_CR84","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3233\/JAD-2012-120469","volume":"31","author":"M Matos","year":"2012","unstructured":"Matos M, Augusto E, Machado NJ et al (2012) Astrocytic adenosine A2A receptors control the amyloid-\u03b2 peptide-induced decrease of glutamate uptake. J Alzheimers Dis 31:555\u2013567","journal-title":"J Alzheimers Dis"},{"key":"11_CR85","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/jnr.20314","volume":"78","author":"P Meerlo","year":"2004","unstructured":"Meerlo P, Roman V, Farkas E et al (2004) Ageing-related decline in adenosine A1 receptor binding in the rat brain: an autoradiographic study. J Neurosci Res 78:742\u2013748","journal-title":"J Neurosci Res"},{"key":"11_CR86","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1471-4159.2009.06351.x","volume":"111","author":"RM Mitchell","year":"2009","unstructured":"Mitchell RM, Neafsey EJ, Collins MA (2009) Essential involvement of the NMDA receptor in ethanol preconditioning-dependent neuroprotection from amyloid-beta in vitro. J Neurochem 111:580\u2013588","journal-title":"J Neurochem"},{"key":"11_CR87","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1212\/WNL.0000000000000733","volume":"83","author":"TJ Montine","year":"2014","unstructured":"Montine TJ, Koroshetz WJ, Babcock D et al (2014) Recommendations of the Alzheimer\u2019s disease-related dementias conference. Neurology 83:851\u2013860","journal-title":"Neurology"},{"key":"11_CR88","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3233\/JAD-160142","volume":"53","author":"A Moreira","year":"2016","unstructured":"Moreira A, Di\u00f3genes MJ, de Mendon\u00e7a A et al (2016) Chocolate consumption is associated with a lower risk of cognitive decline. J Alzheimers Dis 53:85\u201393","journal-title":"J Alzheimers Dis"},{"key":"11_CR89","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/cercor\/bhr255","volume":"22","author":"EC Mormino","year":"2012","unstructured":"Mormino EC, Brandel MG, Madison CM et al (2012) A\u03b2 deposition in aging is associated with increases in brain activation during successful memory encoding. Cereb Cortex 22:1813\u20131823","journal-title":"Cereb Cortex"},{"key":"11_CR90","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrn.2017.29","volume":"18","author":"UC M\u00fcller","year":"2017","unstructured":"M\u00fcller UC, Deller T, Korte M (2017) Not just amyloid: physiological functions of the amyloid precursor protein family. Nat Rev Neurosci 18:281\u2013298","journal-title":"Nat Rev Neurosci"},{"key":"11_CR91","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nn.4018","volume":"18","author":"ES Musiek","year":"2015","unstructured":"Musiek ES, Holtzman DM (2015) Three dimensions of the amyloid hypothesis: time, space and \u2018wingmen\u2019. Nat Neurosci 18:800\u2013806","journal-title":"Nat Neurosci"},{"key":"11_CR92","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3233\/JAD-140675","volume":"42","author":"B Muthaiyah","year":"2014","unstructured":"Muthaiyah B, Essa MM, Lee M et al (2014) Dietary supplementation of walnuts improves memory deficits and learning skills in transgenic mouse model of Alzheimer\u2019s disease. J Alzheimers Dis 42:1397\u20131405","journal-title":"J Alzheimers Dis"},{"key":"11_CR93","doi-asserted-by":"crossref","first-page":"e88508","DOI":"10.1371\/journal.pone.0088508","volume":"9","author":"BV Nagpure","year":"2014","unstructured":"Nagpure BV, Bian JS (2014) Hydrogen sulfide inhibits A2A adenosine receptor agonist induced beta-amyloid production in SH-SY5Y neuroblastoma cells via a cAMP dependent pathway. PLoS One 9:e88508","journal-title":"PLoS One"},{"doi-asserted-by":"crossref","unstructured":"Nehlig A (2018) Interindividual differences in caffeine metabolism and their potential impact on caffeine consumption and biological effects. Pharmacol Rev 70:384\u2013411","key":"11_CR94","DOI":"10.1124\/pr.117.014407"},{"key":"11_CR95","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0165-0173(92)90012-B","volume":"17","author":"A Nehlig","year":"1992","unstructured":"Nehlig A, Daval JL, Debry G (1992) Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Rev 17:139\u2013170","journal-title":"Brain Res Rev"},{"key":"11_CR96","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","volume":"385","author":"T Ngandu","year":"2015","unstructured":"Ngandu T, Lehtisalo J, Solomon A et al (2015) A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomized controlled trial. Lancet 385:2255\u20132263","journal-title":"Lancet"},{"key":"11_CR97","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nn.3930","volume":"18","author":"AG Orr","year":"2015","unstructured":"Orr AG, Hsiao EC, Wang MM et al (2015) Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory. Nat Neurosci 18:423\u2013434","journal-title":"Nat Neurosci"},{"key":"11_CR98","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.nbd.2017.10.014","volume":"110","author":"AG Orr","year":"2017","unstructured":"Orr AG, Lo I, Schumacher H et al (2017) Istradefylline reduces memory deficits in aging mice with amyloid pathology. Neurobiol Dis 110:29\u201336","journal-title":"Neurobiol Dis"},{"key":"11_CR99","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1111\/bph.13180","volume":"172","author":"N Pagnussat","year":"2015","unstructured":"Pagnussat N, Almeida AS, Marques DM et al (2015) Adenosine A2A receptors are necessary and sufficient to trigger memory impairment in adult mice. Br J Pharmacol 172:3831\u20133845","journal-title":"Br J Pharmacol"},{"key":"11_CR100","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/00001756-199209000-00003","volume":"3","author":"O Pagonopoulou","year":"1992","unstructured":"Pagonopoulou O, Angelatou F (1992) Reduction of A1 adenosine receptors in cortex, hippocampus and cerebellum in ageing mouse brain. Neuroreport 3:735\u2013737","journal-title":"Neuroreport"},{"key":"11_CR101","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s12603-014-0563-8","volume":"19","author":"F Panza","year":"2015","unstructured":"Panza F, Solfrizzi V, Barulli MR et al (2015) Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review. J Nutr Health Aging 19:313\u2013328","journal-title":"J Nutr Health Aging"},{"key":"11_CR102","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.tins.2009.05.001","volume":"32","author":"G Perea","year":"2009","unstructured":"Perea G, Navarrete M, Araque A (2009) Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci 32:421\u2013431","journal-title":"Trends Neurosci"},{"key":"11_CR103","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archneurol.2009.266","volume":"66","author":"RC Petersen","year":"2009","unstructured":"Petersen RC, Roberts RO, Knopman DS et al (2009) Mild cognitive impairment: ten years later. Arch Neurol 66:1447\u20131455","journal-title":"Arch Neurol"},{"key":"11_CR104","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.1007\/s12035-015-9491-9","volume":"53","author":"A Pli\u00e1ssova","year":"2016","unstructured":"Pli\u00e1ssova A, Lopes JP, Lemos C et al (2016a) The association of amyloid-\u03b2 protein precursor with \u03b1- and \u03b2-secretases in mouse cerebral cortex synapses is altered in early Alzheimer\u2019s disease. Mol Neurobiol 53:5710\u20135721","journal-title":"Mol Neurobiol"},{"key":"11_CR105","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3233\/JAD-160213","volume":"52","author":"A Pli\u00e1ssova","year":"2016","unstructured":"Pli\u00e1ssova A, Canas PM, Xavier AC et al (2016b) Age-related changes in the synaptic density of amyloid-\u03b2 protein precursor and secretases in the human cerebral cortex. J Alzheimers Dis 52:1209\u20131214","journal-title":"J Alzheimers Dis"},{"key":"11_CR106","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neurobiolaging.2014.10.031","volume":"36","author":"J Popp","year":"2015","unstructured":"Popp J, Wolfsgruber S, Heuser I et al (2015) Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer\u2019s type. Neurobiol Aging 36:601\u2013607","journal-title":"Neurobiol Aging"},{"key":"11_CR107","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.freeradbiomed.2010.07.007","volume":"49","author":"JR Prasanthi","year":"2010","unstructured":"Prasanthi JR, Dasari B, Marwarha G et al (2010) Caffeine protects against oxidative stress and Alzheimer\u2019s disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet. Free Radic Biol Med 49:1212\u20131220","journal-title":"Free Radic Biol Med"},{"key":"11_CR108","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.neurobiolaging.2004.08.012","volume":"26","author":"RD Prediger","year":"2005","unstructured":"Prediger RD, Batista LC, Takahashi RN (2005) Caffeine reverses age-related deficits in olfactory discrimination and social recognition memory in rats. Involvement of adenosine A1 and A2A receptors. Neurobiol Aging 26:957\u2013964","journal-title":"Neurobiol Aging"},{"unstructured":"Prince M, Comas-Herrera A, Knapp M et al (2016) World Alzheimer report. Alzheimer\u2019s Disease International. https:\/\/www.alz.co.uk\/research\/WorldAlzheimerReport2016.pdf","key":"11_CR109"},{"key":"11_CR110","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1073\/pnas.98.2.676","volume":"98","author":"ME Raichle","year":"2001","unstructured":"Raichle ME, MacLeod AM, Snyder AZ et al (2001) A default mode of brain function. PNAS 98:676\u2013682","journal-title":"PNAS"},{"key":"11_CR111","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3389\/fnagi.2016.00333","volume":"8","author":"S Rajaram","year":"2017","unstructured":"Rajaram S, Valls-Pedret C, Cof\u00e1n M et al (2017) The walnuts and healthy aging study (WAHA): protocol for a nutritional intervention trial with walnuts on brain aging. Front Aging Neurosci 8:333","journal-title":"Front Aging Neurosci"},{"key":"11_CR112","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1152\/jn.00896.2002","volume":"90","author":"N Rebola","year":"2003","unstructured":"Rebola N, Sebasti\u00e3o AM, de Mendon\u00e7a A et al (2003) Enhanced adenosine A2A receptor facilitation of synaptic transmission in the hippocampus of aged rats. J Neurophysiol 90:1295\u20131303","journal-title":"J Neurophysiol"},{"key":"11_CR113","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.neuroscience.2005.01.014","volume":"132","author":"N Rebola","year":"2005","unstructured":"Rebola N, Canas PM, Oliveira CR et al (2005) Different synaptic and subsynaptic localization of adenosine A2A receptors in the hippocampus and striatum of the rat. Neuroscience 132:893\u2013903","journal-title":"Neuroscience"},{"key":"11_CR114","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1471-4159.2011.07178.x","volume":"117","author":"N Rebola","year":"2011","unstructured":"Rebola N, Sim\u00f5es AP, Canas PM et al (2011) Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction. J Neurochem 117:100\u2013111","journal-title":"J Neurochem"},{"key":"11_CR115","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3389\/fncel.2015.00521","volume":"9","author":"D Rial","year":"2016","unstructured":"Rial D, Lemos C, Pinheiro H et al (2016) Depression as a glial-based synaptic dysfunction. Front Cell Neurosci 9:521","journal-title":"Front Cell Neurosci"},{"key":"11_CR116","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.neurobiolaging.2007.03.025","volume":"29","author":"RJ Rodrigues","year":"2008","unstructured":"Rodrigues RJ, Canas PM, Lopes LV et al (2008) Modification of adenosine modulation of acetylcholine release in the hippocampus of aged rats. Neurobiol Aging 29:1597\u20131601","journal-title":"Neurobiol Aging"},{"issue":"Suppl 1","key":"11_CR117","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.3233\/JAD-2010-091387","volume":"20","author":"C Santos","year":"2010","unstructured":"Santos C, Costa J, Santos J et\u00a0al (2010) Caffeine intake and dementia: systematic review and meta-analysis. J Alzheimers Dis 20(Suppl 1):S187\u2013S204","journal-title":"J Alzheimers Dis"},{"key":"11_CR118","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1212\/01.wnl.0000260698.46517.8f","volume":"68","author":"SW Scheff","year":"2007","unstructured":"Scheff SW, Price DA, Schmitt FA et al (2007) Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 68:1501\u20131508","journal-title":"Neurology"},{"key":"11_CR120","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1038\/sj.bjp.0703736","volume":"131","author":"AM Sebasti\u00e3o","year":"2000","unstructured":"Sebasti\u00e3o AM, Cunha RA, de Mendon\u00e7a A et al (2000) Modification of adenosine modulation of synaptic transmission in the hippocampus of aged rats. Br J Pharmacol 131:1629\u20131634","journal-title":"Br J Pharmacol"},{"key":"11_CR121","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe DJ (2002) Alzheimer\u2019s disease is a synaptic failure. Science 298:789\u2013791","journal-title":"Science"},{"key":"11_CR122","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med 8:595\u2013608","journal-title":"EMBO Mol Med"},{"key":"11_CR123","doi-asserted-by":"crossref","first-page":"a011460","DOI":"10.1101\/cshperspect.a011460","volume":"2","author":"D Selkoe","year":"2012","unstructured":"Selkoe D, Mandelkow E, Holtzman D (2012) Deciphering Alzheimer disease. Cold Spring Harb Perspect Med 2:a011460","journal-title":"Cold Spring Harb Perspect Med"},{"key":"11_CR124","doi-asserted-by":"crossref","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E et al (2011) Neuropathological alterations in Alzheimer\u2019s disease. Cold Spring Harb Perspect Med 1:a006189","journal-title":"Cold Spring Harb Perspect Med"},{"key":"11_CR125","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"GM Shankar","year":"2008","unstructured":"Shankar GM, Li S, Mehta TH et al (2008) Amyloid-beta protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory. Nat Med 14:837\u2013842","journal-title":"Nat Med"},{"key":"11_CR126","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.nbd.2013.05.013","volume":"58","author":"C Simonin","year":"2013","unstructured":"Simonin C, Duru C, Salleron J et\u00a0al (2013) Association between caffeine intake and age at onset in Huntington\u2019s disease. Neurobiol Dis 58:179\u2013182","journal-title":"Neurobiol Dis"},{"key":"11_CR127","doi-asserted-by":"crossref","first-page":"520","DOI":"10.2174\/156720511796391809","volume":"8","author":"V Solfrizzi","year":"2011","unstructured":"Solfrizzi V, Frisardi V, Seripa D et al (2011) Mediterranean diet in predementia and dementia syndromes. Curr Alzheimer Res 8:520\u2013542","journal-title":"Curr Alzheimer Res"},{"key":"11_CR128","first-page":"S465","volume":"1","author":"A Solomon","year":"2013","unstructured":"Solomon A, Kivipelto M, Soininen H (2013) Prevention of Alzheimer\u2019s disease: moving backward through the lifespan. J Alzheimers Dis 1:S465\u2013S469","journal-title":"J Alzheimers Dis"},{"key":"11_CR129","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0736-5748(97)00028-2","volume":"15","author":"B Sperl\u00e1gh","year":"1997","unstructured":"Sperl\u00e1gh B, Zsilla G, Baranyi M et al (1997) Age-dependent changes of presynaptic neuromodulation via A1 adenosine receptors in rat hippocampal slices. Int J Dev Neurosci 15:739\u2013747","journal-title":"Int J Dev Neurosci"},{"key":"11_CR130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12017-009-8109-7","volume":"12","author":"RA Sperling","year":"2010","unstructured":"Sperling RA, Dickerson BC, Pihlajamaki M et al (2010) Functional alterations in memory networks in early Alzheimer\u2019s disease. NeuroMolecular Med 12:27\u201343","journal-title":"NeuroMolecular Med"},{"key":"11_CR131","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA et al (2011) Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7:280\u2013292","journal-title":"Alzheimers Dement"},{"issue":"Suppl 1","key":"11_CR132","first-page":"S5","volume":"33","author":"RE Tanzi","year":"2013","unstructured":"Tanzi RE (2013) A brief history of Alzheimer\u2019s disease gene discovery. J Alzheimers Dis 33(Suppl 1):S5\u2013S13","journal-title":"J Alzheimers Dis"},{"doi-asserted-by":"crossref","unstructured":"Tariq S, Barber PA (2017) Dementia risk and prevention by targeting modifiable vascular risk factors. J Neurochem 144:565","key":"11_CR133","DOI":"10.1111\/jnc.14132"},{"key":"11_CR134","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.brainres.2016.11.011","volume":"1655","author":"V Tentolouris-Piperas","year":"2017","unstructured":"Tentolouris-Piperas V, Ryan NS, Thomas DL et al (2017) Brain imaging evidence of early involvement of subcortical regions in familial and sporadic Alzheimer\u2019s disease. Brain Res 1655:23\u201332","journal-title":"Brain Res"},{"key":"11_CR135","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry RD, Masliah E, Salmon DP et al (1991) Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572\u2013580","journal-title":"Ann Neurol"},{"key":"11_CR136","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ana.21321","volume":"63","author":"T Tomiyama","year":"2008","unstructured":"Tomiyama T, Nagata T, Shimada H et al (2008) A new amyloid beta variant favoring oligomerization in Alzheimer\u2019s-type dementia. Ann Neurol 63:377\u2013387","journal-title":"Ann Neurol"},{"key":"11_CR137","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3233\/JAD-150374","volume":"47","author":"M Travassos","year":"2015","unstructured":"Travassos M, Santana I, Baldeiras I et al (2015) Does caffeine consumption modify cerebrospinal fluid amyloid-\u03b2 levels in patients with Alzheimer\u2019s disease? J Alzheimers Dis 47:1069\u20131078","journal-title":"J Alzheimers Dis"},{"key":"11_CR138","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0306-4522(93)90533-L","volume":"5","author":"J U\u0142as","year":"1993","unstructured":"U\u0142as J, Brunner LC, Nguyen L et al (1993) Reduced density of adenosine A1 receptors and preserved coupling of adenosine A1 receptors to G proteins in Alzheimer hippocampus: a quantitative autoradiographic study. Neuroscience 5:843\u2013854","journal-title":"Neuroscience"},{"key":"11_CR139","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.ejcn.1602495","volume":"61","author":"BM Gelder van","year":"2007","unstructured":"van Gelder BM, Buijsse B, Tijhuis M et al (2007) Coffee consumption is inversely associated with cognitive decline in elderly European men: the FINE study. Eur J Clin Nutr 61:226\u2013232","journal-title":"Eur J Clin Nutr"},{"key":"11_CR140","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(10)70325-2","volume":"10","author":"PB Verghese","year":"2011","unstructured":"Verghese PB, Castellano JM, Holtzman DM (2011) Apolipoprotein E in Alzheimer\u2019s disease and other neurological disorders. Lancet Neurol 10:241\u2013252","journal-title":"Lancet Neurol"},{"key":"11_CR141","doi-asserted-by":"crossref","first-page":"11915","DOI":"10.1038\/ncomms11915","volume":"7","author":"S Viana da Silva","year":"2016","unstructured":"Viana da Silva S, Haberl MG, Zhang P et al (2016) Early synaptic deficits in the APP\/PS1 mouse model of Alzheimer\u2019s disease involve neuronal adenosine A2A receptors. Nat Commun 7:11915","journal-title":"Nat Commun"},{"key":"11_CR142","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neulet.2013.05.052","volume":"548","author":"C Vollert","year":"2013","unstructured":"Vollert C, Forkuo GS, Bond RA et al (2013) Chronic treatment with DCPCX, an adenosine A1 antagonist, worsens long-term memory. Neurosci Lett 548:296\u2013300","journal-title":"Neurosci Lett"},{"key":"11_CR143","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jalz.2014.11.001","volume":"11","author":"MW Weiner","year":"2015","unstructured":"Weiner MW, Veitch DP, Aisen PS et al (2015) 2014 update of the Alzheimer\u2019s Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement 11:e1\u2013e120","journal-title":"Alzheimers Dement"},{"key":"11_CR144","doi-asserted-by":"crossref","first-page":"11458","DOI":"10.1038\/s41598-017-11574-6","volume":"7","author":"NY Yu","year":"2017","unstructured":"Yu NY, Bieder A, Raman A et al (2017) Acute doses of caffeine shift nervous system cell expression profiles toward promotion of neuronal projection growth. Sci Rep 7:11458","journal-title":"Sci Rep"},{"key":"11_CR145","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.brainres.2011.08.036","volume":"1417","author":"R Zeitlin","year":"2011","unstructured":"Zeitlin R, Patel S, Burgess S et al (2011) Caffeine induces beneficial changes in PKA signaling and JNK and ERK activities in the striatum and cortex of Alzheimer\u2019s transgenic mice. Brain Res 1417:127\u2013136","journal-title":"Brain Res"}],"container-title":["The Adenosine Receptors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-90808-3_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T02:51:01Z","timestamp":1751770261000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-90808-3_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783319908076","9783319908083"],"references-count":145,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-90808-3_11","relation":{},"subject":[],"published":{"date-parts":[[2018]]}}}